Knott David M Jr - Q3 2023 holdings

$262 Thousand is the total value of Knott David M Jr's 135 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 103.2% .

 Value Shares↓ Weighting
SIVB ExitSVB Financial Group$0-48
-100.0%
0.00%
EMB ExitiShares JPMorgan USD Emerging Markets Bond$0-17
-100.0%
0.00%
EZU ExitiShares MSCI Eurozone$0-55
-100.0%
-0.00%
EFV Exitishares Msci Value Index Fund$0-63
-100.0%
-0.00%
EBND ExitSPDR Sec SER TR Bloom Emer Mkts Loc BD etf$0-147
-100.0%
-0.00%
HYG ExitiShares iBoxx $ High Yield Corporate Bond$0-32
-100.0%
-0.00%
EWG ExitiShares MSCI Germany$0-150
-100.0%
-0.00%
EWU ExitiShares MSCI United Kingdom$0-116
-100.0%
-0.00%
EWUS ExitiShares MSCI United Kingdom Small-Cap$0-246
-100.0%
-0.00%
NYF ExitiShares New York Muni Bond$0-242
-100.0%
-0.01%
SCHW ExitCharles Schwab Corporation$0-284
-100.0%
-0.01%
IEMG ExitiShares Core MSCI Emerging Markets$0-363
-100.0%
-0.01%
CVS ExitCVS Caremark Corporation$0-258
-100.0%
-0.01%
AMT ExitAmerican Tower Corp.$0-93
-100.0%
-0.01%
CB ExitChubb Corporation$0-121
-100.0%
-0.01%
TGT ExitTarget Corporation$0-166
-100.0%
-0.01%
ARMK ExitAramark$0-651
-100.0%
-0.01%
ExitLinde PLC$0-70
-100.0%
-0.01%
ZBH ExitZimmer Biomet Holdings Inc$0-190
-100.0%
-0.01%
PWR ExitQuanta Services, Inc.$0-176
-100.0%
-0.01%
IEFA ExitiShares Core MSCI EAFE$0-633
-100.0%
-0.02%
ExitLeap Therapeutics, Inc.$0-28,730
-100.0%
-0.04%
PSTX ExitPoseida Therapeutics, Inc.$0-140,921
-100.0%
-0.10%
ExitQualTek Services Inc. - Warrants$0-25,000
-100.0%
-0.12%
CLBRWS ExitColombier Acquisition Corp. Wts.$0-26,666
-100.0%
-0.12%
XAIR ExitBeyond Air Inc.$0-87,522
-100.0%
-0.15%
TMKRW ExitTastemaker Acquisition Corp. Warrants$0-100,000
-100.0%
-0.46%
ExitFTAI Infrastructure LLC$0-425,000
-100.0%
-0.62%
HZNP ExitHorizon Therapeutics Public Ltd. Company$0-27,190
-100.0%
-1.11%
SNY ExitSanofi$0-56,000
-100.0%
-1.20%
ISEE ExitIVERIC bio, Inc.$0-87,000
-100.0%
-1.36%
AGACWS ExitAfrican Gold Acquistion Corp. Warrants$0-450,750
-100.0%
-2.06%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Calumet Specialty Products Partners, LP8Q3 202331.5%
Alphabet Inc-Cl C8Q3 20235.6%
DocGo, Inc.8Q3 20235.8%
Ligand Pharmaceuticals Incorporated8Q3 20234.3%
Franklin BSP Realty Trust, Inc.8Q3 20234.9%
Midwest Holding Inc.8Q3 20234.1%
Coliseum Acquisition Corp.WTS8Q3 20232.4%
Pfizer Inc.8Q3 20233.2%
Jazz Pharmaceuticals PLC8Q3 20231.5%
Vertex Pharmaceuticals, Inc.8Q3 20232.1%

View Knott David M Jr's complete holdings history.

Latest significant ownerships (13-D/G)
Knott David M Jr Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Calumet Specialty Products Partners, L.P.November 08, 20214,292,2005.4%

View Knott David M Jr's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
42023-12-22
SC 13D/A2023-12-22
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-11
13F-HR2023-02-13
13F-HR2022-11-10
42022-09-26
42022-09-02

View Knott David M Jr's complete filings history.

Compare quarters

Export Knott David M Jr's holdings